/
, and our Consolidated Financial Statements, the notes to those statements and other financial information contained elsewhere in this Annual Report. For purposes of this Management s Discussion and Analysis within this Annual Report, all monetary amounts are stated in thousands except for par values and per share amounts, unless otherwise stated.
$12.20
$0.51 (-4.01%)
Price from 2 days ago
Operating margin is thin at 0.70%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 13.8% YoY. The question is whether this is cyclical or a structural shift.
At 144x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Free cash flow declined 127% versus the prior year, cash generation momentum has weakened.
143.5x earnings, 543.0x FCF. The market is pricing in years of above-average growth. If that thesis breaks, downside from multiple compression alone could be 30%+. This is a stock where you're paying for the future, not the present.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$58M
▼ -13.8% YoY
Net Income (TTM)
$348K
▼ -103.9% YoY
Op. Margin
0.91%
▼ -1.9pp YoY
ROIC
0.74%
▼ -1.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$219K
▼ -127.4% YoY
Op. Cash Flow (TTM)
$2M
▼ -86.3% YoY
Net Debt
-$12M
Net Cash Position
Cash & Equiv.
$16M
5Y CAGR: +1.2%
Continue Research